These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31711973)

  • 1. The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo.
    Botros SS; El-Lakkany NM; Seif El-Din SH; William S; Sabra AN; Hammam OA; de Koning HP
    Exp Parasitol; 2020 Jan; 208():107793. PubMed ID: 31711973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity.
    Botros SS; William S; Sabra AA; El-Lakkany NM; Seif El-Din SH; García-Rubia A; Sebastián-Pérez V; Blaazer AR; de Heuvel E; Sijm M; Zheng Y; Salado IG; Munday JC; Maes L; de Esch IJP; Sterk GJ; Augustyns K; Leurs R; Gil C; De Koning HP
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():35-43. PubMed ID: 30669086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Target or Not to Target
    Zheng Y; Schroeder S; Kanev GK; Botros SS; William S; Sabra AA; Maes L; Caljon G; Gil C; Martinez A; Salado IG; Augustyns K; Edink E; Sijm M; de Heuvel E; de Esch IJP; van der Meer T; Siderius M; Sterk GJ; Brown D; Leurs R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
    Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
    Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
    Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
    J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
    Sabra AA; Salem MB; William S; Hammam OA; El-Lakkany NM
    Exp Parasitol; 2022 Aug; 239():108293. PubMed ID: 35667394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.
    Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS
    Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
    Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate.
    Hanallah S; El-Lakkany N; Mahmoud S; Mousa M; Botros S
    APMIS; 2003 Dec; 111(12):1125-32. PubMed ID: 14678022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
    Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
    Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
    Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
    Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
    Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
    Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
    Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
    Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
    el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
    Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antischistosomal effects of green and chemically synthesized silver nanoparticles: In vitro and in vivo murine model.
    Hamdan ZK; Soliman MI; Taha HA; Khalil MMH; Nigm AH
    Acta Trop; 2023 Aug; 244():106952. PubMed ID: 37236335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.